Evaluation of the effect of L-carnitine administration on survival rates in chronic hemodialysis patients

Evaluation of the effect of L-carnitine administration on survival rates in chronic hemodialysis patients - Effect of L- carnitine administration on survival rates in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034152

Enrollment

2500

Registered

2018-09-14

Start date

2018-09-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary carnitine deficiency

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients over the age of 20 years with end stage renal disease undergoing hemodialysis

Exclusion criteria

Exclusion criteria: Patients under the age of 20 years old Patients undergoing combination therapy with peritoneal dialysis and hemodialysis Others not inadequate judged by a physician

Design outcomes

Primary

Measure	Time frame
Improvement of survival rates by administration of L-carnitine	—

Countries

Japan

Contacts

Public ContactKei Fukami

Kurume University Division of Nephrology, Department on Medicine

fukami@med.kurume-u.ac.jp0942-31-7763

Outcome results